Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
ClinicalTrials.gov study NCT05933070. IPD Sharing: NO. Countries: 2. Publications: 25.
Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old
ClinicalTrials.gov study NCT00590837. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
ClinicalTrials.gov study NCT02027064. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Oral Arsenic Trioxide for NPM1-mutated AML
ClinicalTrials.gov study NCT04689815. IPD Sharing: NO. Countries: 1. Publications: 8.
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
ClinicalTrials.gov study NCT02192619. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers
ClinicalTrials.gov study NCT05541224. IPD Sharing: NO. Countries: 1. Publications: 13.
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
ClinicalTrials.gov study NCT03023384. IPD Sharing: NO. Countries: 1. Publications: 49.
A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
ClinicalTrials.gov study NCT04150029. IPD Sharing: YES. Countries: 10. Publications: 0.
Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）
ClinicalTrials.gov study NCT01690507. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ClinicalTrials.gov study NCT05735184. IPD Sharing: NO. Countries: 1. Publications: 0.
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01385423. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety Study of SGN-CD33A in AML Patients
ClinicalTrials.gov study NCT01902329. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML
ClinicalTrials.gov study NCT02461537. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01211457. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00104468. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS
ClinicalTrials.gov study NCT02477787. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Molecular Diagnostic Platform for AML
ClinicalTrials.gov study NCT04446741. IPD Sharing: Not stated. Countries: 1. Publications: 5.
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
ClinicalTrials.gov study NCT05907057. IPD Sharing: YES. Countries: 4. Publications: 1.
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
ClinicalTrials.gov study NCT00927498. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
ClinicalTrials.gov study NCT00266136. IPD Sharing: Not stated. Countries: 1. Publications: 12.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.